D
Dan Liao
Researcher at Baylor College of Medicine
Publications - 4
Citations - 431
Dan Liao is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Endothelium & High-density lipoprotein. The author has an hindex of 4, co-authored 4 publications receiving 408 citations. Previous affiliations of Dan Liao include Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Hyperhomocysteinemia Decreases Circulating High-Density Lipoprotein by Inhibiting Apolipoprotein A-I Protein Synthesis and Enhancing HDL Cholesterol Clearance
Dan Liao,Hongmei Tan,Rutai Hui,Zhaohui Li,Xiaohua Jiang,John W. Gaubatz,Fan Yang,William Durante,Lawrence Chan,Andrew I. Schafer,Henry J. Pownall,Xiao-feng Yang,Xiao-feng Yang,Xiao-feng Yang,Hong Wang,Hong Wang,Hong Wang +16 more
TL;DR: Findings indicate that HHcy inhibits reverse cholesterol transport by reducing circulating HDL via inhibiting apoA-I protein synthesis and enhancing HDL-C clearance.
Journal ArticleDOI
Hyperhomocystinemia Impairs Endothelial Function and eNOS Activity via PKC Activation
Xiaohua Jiang,Fan Yang,Hongmei Tan,Dan Liao,Robert M. Bryan,Jaspreet K. Randhawa,Rolando E. Rumbaut,William Durante,Andrew I. Schafer,Xiaofeng Yang,Hong Wang +10 more
TL;DR: The data suggest that HHcy impairs endothelial function and eNOS activity, primarily through PKC activation.
Journal ArticleDOI
Hyperhomocysteinemia inhibits post-injury reendothelialization in mice
Hongmei Tan,Xiaohua Jiang,Xiaohua Jiang,Fan Yang,Fan Yang,Zhaohui Li,Zhaohui Li,Dan Liao,Dan Liao,JoAnn Trial,Mark J. Magera,William Durante,William Durante,Xiaofeng Yang,Hong Wang,Hong Wang +15 more
TL;DR: The capacity of Hcy to inhibit proliferation and migration of EC may be responsible for impaired reendothelialization and contribute to arteriosclerosis in HHcy and a convenient and accurate mouse model of carotid injury is established.
Journal ArticleDOI
Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease
Dan Liao,Xiaofeng Yang,Hong Wang +2 more
TL;DR: These studies suggest that Hcy-induced HDL-C and apoA-I inhibition represent a novel mechanism by which Hcy induces atherosclerotic CVD.